A detailed history of Cutler Group LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Cutler Group LP holds 1,480 shares of ABBV stock, worth $244,185. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,480
Previous 1,667 11.22%
Holding current value
$244,185
Previous $258,000 4.26%
% of portfolio
0.09%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $29,886 - $34,052
-187 Reduced 11.22%
1,480 $269,000
Q4 2023

Jan 18, 2024

SELL
$137.6 - $154.97 $99,622 - $112,198
-724 Reduced 30.28%
1,667 $258,000
Q3 2023

Nov 07, 2023

SELL
$133.59 - $154.65 $232,446 - $269,091
-1,740 Reduced 42.12%
2,391 $356,000
Q2 2023

Jul 18, 2023

SELL
$132.51 - $164.9 $160,602 - $199,858
-1,212 Reduced 22.68%
4,131 $556,000
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $1.31 Million - $1.51 Million
-9,041 Reduced 62.85%
5,343 $851,000
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $910,633 - $1.09 Million
6,584 Added 84.41%
14,384 $2.32 Million
Q3 2022

Oct 25, 2022

SELL
$134.21 - $153.93 $416,453 - $477,644
-3,103 Reduced 28.46%
7,800 $1.05 Million
Q2 2022

Aug 04, 2022

BUY
$137.62 - $174.96 $299,048 - $380,188
2,173 Added 24.89%
10,903 $1.67 Million
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $2.71 Million - $3.37 Million
-20,557 Reduced 70.19%
8,730 $1.42 Million
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $1.26 Million - $1.59 Million
11,706 Added 66.58%
29,287 $3.97 Million
Q3 2021

Oct 26, 2021

SELL
$106.4 - $120.78 $699,686 - $794,249
-6,576 Reduced 27.22%
17,581 $1.9 Million
Q2 2021

Jul 19, 2021

BUY
$105.21 - $117.21 $849,886 - $946,822
8,078 Added 50.24%
24,157 $2.72 Million
Q1 2021

Apr 26, 2021

SELL
$102.3 - $112.62 $1.85 Million - $2.04 Million
-18,114 Reduced 52.98%
16,079 $1.74 Million
Q4 2020

Jan 21, 2021

BUY
$80.49 - $108.67 $2.41 Million - $3.26 Million
29,979 Added 711.41%
34,193 $3.66 Million
Q3 2020

Oct 27, 2020

SELL
$85.91 - $100.83 $492,178 - $577,655
-5,729 Reduced 57.62%
4,214 $369,000
Q2 2020

Jul 22, 2020

SELL
$73.37 - $98.18 $259,509 - $347,262
-3,537 Reduced 26.24%
9,943 $976,000
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $694,020 - $1.05 Million
10,760 Added 395.59%
13,480 $1.03 Million
Q4 2019

Feb 06, 2020

SELL
$72.13 - $90.25 $72,130 - $90,250
-1,000 Reduced 26.88%
2,720 $240,000
Q3 2019

Oct 28, 2019

BUY
$62.98 - $75.72 $130,242 - $156,588
2,068 Added 125.18%
3,720 $281,000
Q2 2019

Aug 09, 2019

BUY
$65.7 - $83.98 $16,950 - $21,666
258 Added 18.51%
1,652 $120,000
Q1 2019

May 10, 2019

SELL
$77.14 - $90.79 $509,586 - $599,758
-6,606 Reduced 82.58%
1,394 $112,000
Q4 2018

Feb 05, 2019

BUY
$77.85 - $96.01 $467,099 - $576,060
6,000 Added 300.0%
8,000 $737,000
Q3 2018

Nov 07, 2018

BUY
$88.91 - $98.84 $44,455 - $49,420
500 Added 33.33%
2,000 $189,000
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $161,873 - $191,532
-1,803 Reduced 54.59%
1,500 $138,000
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $630,544 - $844,358
-6,853 Reduced 67.48%
3,303 $312,000
Q4 2017

Jan 17, 2018

BUY
$89.56 - $98.21 $88,395 - $96,933
987 Added 10.76%
10,156 $982,000
Q3 2017

Oct 17, 2017

BUY
$69.85 - $89.22 $640,454 - $818,058
9,169
9,169 $814,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.